Clinical Trial Update: Twelve Month Follow-Up of CP0108

View source ↗

Summary

A twelve-month follow-up update for CP0108 in Actinic keratosis, with the trial status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• CP0108

Snippet

Sponsor: DUSA Pharmaceuticals, Inc. | Conditions: Actinic Keratosis | Status: COMPLETED